|
Volumn 38, Issue 14, 1999, Pages 4382-4388
|
Inhibition of topoisomerase II catalytic activity by two ruthenium compounds: A ligand-dependent mode of action
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE;
ANTINEOPLASTIC AGENT;
DNA TOPOISOMERASE (ATP HYDROLYSING);
RUTHENIUM COMPLEX;
RUTHENIUM SALICYLALDOXIME;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CROSS LINKING;
DNA CLEAVAGE;
DNA DRUG COMPLEX;
DRUG DNA BINDING;
DRUG DNA INTERACTION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IMMUNOPRECIPITATION;
MITOSIS INHIBITION;
PRIORITY JOURNAL;
ADENOSINE TRIPHOSPHATASES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CATALYSIS;
DIMETHYL SULFOXIDE;
DNA;
DNA LIGASES;
DNA TOPOISOMERASES, TYPE II;
DRUG INTERACTIONS;
ENZYME ACTIVATION;
ENZYME STABILITY;
GROWTH INHIBITORS;
LIGANDS;
MACROMOLECULAR SUBSTANCES;
ORGANOMETALLIC COMPOUNDS;
RATS;
RUTHENIUM COMPOUNDS;
TUMOR CELLS, CULTURED;
|
EID: 0033528670
PISSN: 00062960
EISSN: None
Source Type: Journal
DOI: 10.1021/bi981990s Document Type: Article |
Times cited : (99)
|
References (37)
|